Halozyme Therapeutics, Inc. (HALO)
USD 57.78
(-3.33%)
USD 57.78
(-3.33%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 636.89 Million USD | 22.29% |
| 2022 | 520.81 Million USD | 43.91% |
| 2021 | 361.89 Million USD | 61.4% |
| 2020 | 224.22 Million USD | 49.04% |
| 2019 | 150.44 Million USD | 6.15% |
| 2018 | 141.72 Million USD | -50.35% |
| 2017 | 285.46 Million USD | 151.54% |
| 2016 | 113.48 Million USD | 7.25% |
| 2015 | 105.81 Million USD | 101.16% |
| 2014 | 52.6 Million USD | 8.34% |
| 2013 | 48.55 Million USD | 17.76% |
| 2012 | 41.23 Million USD | -26.15% |
| 2011 | 55.82 Million USD | 341.72% |
| 2010 | 12.63 Million USD | -5.39% |
| 2009 | 13.35 Million USD | 58.44% |
| 2008 | 8.43 Million USD | 136.91% |
| 2007 | 3.55 Million USD | 553.34% |
| 2006 | 544.75 Thousand USD | 624.01% |
| 2005 | 75.24 Thousand USD | 0.0% |
| 2004 | - USD | 100.0% |
| 2003 | -1298.00 USD | -103.41% |
| 2002 | 38.09 Thousand USD | 331.52% |
| 2001 | 8828.00 USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 173.98 Million USD | 16.15% |
| 2024 Q1 | 149.78 Million USD | -15.73% |
| 2024 Q3 | 240.65 Million USD | 38.32% |
| 2023 Q2 | 170.96 Million USD | 34.65% |
| 2023 Q3 | 161.21 Million USD | -5.71% |
| 2023 Q4 | 177.74 Million USD | 10.25% |
| 2023 FY | 636.89 Million USD | 22.29% |
| 2023 Q1 | 126.97 Million USD | -8.9% |
| 2022 Q3 | 161.65 Million USD | 36.51% |
| 2022 Q1 | 101.35 Million USD | 26.04% |
| 2022 Q2 | 118.42 Million USD | 16.84% |
| 2022 FY | 520.81 Million USD | 43.91% |
| 2022 Q4 | 139.37 Million USD | -13.78% |
| 2021 FY | 361.89 Million USD | 61.4% |
| 2021 Q4 | 80.41 Million USD | -17.3% |
| 2021 Q3 | 97.24 Million USD | -14.28% |
| 2021 Q2 | 113.43 Million USD | 60.21% |
| 2021 Q1 | 70.8 Million USD | -25.81% |
| 2020 Q2 | 49.48 Million USD | 152.88% |
| 2020 Q1 | 19.56 Million USD | -47.08% |
| 2020 Q3 | 59.74 Million USD | 20.75% |
| 2020 FY | 224.22 Million USD | 49.04% |
| 2020 Q4 | 95.43 Million USD | 59.72% |
| 2019 Q2 | 37.27 Million USD | -28.74% |
| 2019 Q3 | 23.89 Million USD | -35.88% |
| 2019 Q4 | 36.97 Million USD | 54.74% |
| 2019 FY | 150.44 Million USD | 6.15% |
| 2019 Q1 | 52.3 Million USD | -4.23% |
| 2018 Q1 | 27.82 Million USD | -84.72% |
| 2018 FY | 141.72 Million USD | -50.35% |
| 2018 Q4 | 54.61 Million USD | 119.05% |
| 2018 Q3 | 24.93 Million USD | -27.46% |
| 2018 Q2 | 34.36 Million USD | 23.53% |
| 2017 Q4 | 182.07 Million USD | 228.66% |
| 2017 Q3 | 55.39 Million USD | 113.38% |
| 2017 Q2 | 25.96 Million USD | 17.88% |
| 2017 Q1 | 22.02 Million USD | -28.96% |
| 2017 FY | 285.46 Million USD | 151.54% |
| 2016 Q3 | 22.71 Million USD | -9.23% |
| 2016 Q4 | 31 Million USD | 36.45% |
| 2016 FY | 113.48 Million USD | 7.25% |
| 2016 Q2 | 25.02 Million USD | -27.95% |
| 2016 Q1 | 34.73 Million USD | -20.69% |
| 2015 Q4 | 43.8 Million USD | 200.0% |
| 2015 Q3 | 14.6 Million USD | -58.57% |
| 2015 Q2 | 35.24 Million USD | 189.52% |
| 2015 Q1 | 12.17 Million USD | -49.76% |
| 2015 FY | 105.81 Million USD | 101.16% |
| 2014 Q2 | 12.46 Million USD | 93.31% |
| 2014 FY | 52.6 Million USD | 8.34% |
| 2014 Q1 | 6.44 Million USD | -28.05% |
| 2014 Q4 | 24.23 Million USD | 156.0% |
| 2014 Q3 | 9.46 Million USD | -24.04% |
| 2013 Q3 | 15.33 Million USD | 16.41% |
| 2013 FY | 48.55 Million USD | 17.76% |
| 2013 Q1 | 11.09 Million USD | -47.52% |
| 2013 Q4 | 8.95 Million USD | -41.56% |
| 2013 Q2 | 13.16 Million USD | 18.71% |
| 2012 Q4 | 21.13 Million USD | 313.88% |
| 2012 Q1 | 7.36 Million USD | 212.93% |
| 2012 Q3 | 5.1 Million USD | -32.92% |
| 2012 Q2 | 7.61 Million USD | 3.32% |
| 2012 FY | 41.23 Million USD | -26.15% |
| 2011 FY | 55.82 Million USD | 341.72% |
| 2011 Q1 | 7.53 Million USD | 180.67% |
| 2011 Q2 | 23.01 Million USD | 205.5% |
| 2011 Q3 | 22.93 Million USD | -0.35% |
| 2011 Q4 | 2.35 Million USD | -89.73% |
| 2010 Q4 | 2.68 Million USD | -20.82% |
| 2010 FY | 12.63 Million USD | -5.39% |
| 2010 Q3 | 3.38 Million USD | 8.29% |
| 2010 Q2 | 3.12 Million USD | -8.91% |
| 2010 Q1 | 3.43 Million USD | -45.32% |
| 2009 Q1 | 2.76 Million USD | -5.68% |
| 2009 FY | 13.35 Million USD | 58.44% |
| 2009 Q2 | 1.38 Million USD | -50.11% |
| 2009 Q4 | 6.28 Million USD | 114.74% |
| 2009 Q3 | 2.92 Million USD | 111.88% |
| 2008 Q3 | 2.33 Million USD | 66.88% |
| 2008 FY | 8.43 Million USD | 136.91% |
| 2008 Q4 | 2.93 Million USD | 25.88% |
| 2008 Q2 | 1.39 Million USD | -20.99% |
| 2008 Q1 | 1.76 Million USD | 35.12% |
| 2007 Q3 | 883.42 Thousand USD | 39.56% |
| 2007 Q4 | 1.3 Million USD | 48.14% |
| 2007 Q1 | 733.98 Thousand USD | 90.68% |
| 2007 FY | 3.55 Million USD | 553.34% |
| 2007 Q2 | 632.99 Thousand USD | -13.76% |
| 2006 Q1 | 50.32 Thousand USD | 43.74% |
| 2006 FY | 544.75 Thousand USD | 624.01% |
| 2006 Q3 | 6384.00 USD | -93.81% |
| 2006 Q4 | 384.92 Thousand USD | 5929.56% |
| 2006 Q2 | 103.12 Thousand USD | 104.93% |
| 2005 Q2 | 24.67 Thousand USD | 0.0% |
| 2005 Q4 | 35 Thousand USD | 125.09% |
| 2005 FY | 75.24 Thousand USD | 0.0% |
| 2005 Q3 | 15.55 Thousand USD | -36.98% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | - USD | 100.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 FY | - USD | 100.0% |
| 2004 Q3 | - USD | 0.0% |
| 2003 FY | -1298.00 USD | -103.41% |
| 2003 Q1 | 2003.00 USD | 238.04% |
| 2003 Q2 | 7284.00 USD | 263.65% |
| 2003 Q4 | -11.66 Thousand USD | -425.59% |
| 2003 Q3 | 3584.00 USD | -50.8% |
| 2002 Q3 | 13.11 Thousand USD | 3595.21% |
| 2002 Q1 | 26.07 Thousand USD | 0.0% |
| 2002 Q4 | -1451.00 USD | -111.06% |
| 2002 FY | 38.09 Thousand USD | 331.52% |
| 2002 Q2 | 355.00 USD | -98.64% |
| 2001 FY | 8828.00 USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -1574.93% |
| Alkermes plc | 1.37 Billion USD | 53.67% |
| Agenus Inc. | 139.61 Million USD | -356.177% |
| Aptorum Group Limited | -1.11 Million USD | 57236.347% |
| Ardelyx, Inc. | 106.66 Million USD | -497.118% |
| Dyadic International, Inc. | 922.95 Thousand USD | -68905.598% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -2924.035% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 364365.084% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 4867.924% |
| Novavax, Inc. | 639.93 Million USD | 0.476% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 1459.747% |
| Pyxis Oncology, Inc. | -2 Million USD | 31944.6% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 123350.494% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -3244.494% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 1441423.436% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 120952.372% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 748.454% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -79312.968% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 776797.561% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -370.834% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -7991.627% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 756.928% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 58.041% |
| AlloVir, Inc. | -398 Thousand USD | 160123.116% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -164.561% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -150110.377% |
| Bicycle Therapeutics plc | -129.52 Million USD | 591.733% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -530643.333% |
| ChromaDex Corporation | 50.78 Million USD | -1154.218% |
| Chimerix, Inc. | 324 Thousand USD | -196471.605% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 2143.439% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 920.758% |
| CRISPR Therapeutics AG | 240.95 Million USD | -164.319% |
| Precision BioSciences, Inc. | 40.47 Million USD | -1473.661% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 748.811% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1000.88% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1000.88% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -3742.022% |
| ImmuCell Corporation | 4.39 Million USD | -14387.053% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 700.145% |
| Immix Biopharma, Inc. | -5468.00 USD | 11647722.531% |
| Incyte Corporation | 3.44 Billion USD | 81.489% |
| Innoviva, Inc. | 261.06 Million USD | -143.959% |
| IO Biotech, Inc. | -756 Thousand USD | 84344.974% |
| Jaguar Health, Inc. | 7.72 Million USD | -8145.624% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 96017.47% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -431.838% |
| ContextLogic Inc. | 59 Million USD | -979.478% |
| MiMedx Group, Inc. | 266.84 Million USD | -138.677% |
| MEI Pharma, Inc. | 49.32 Million USD | -1191.163% |
| NextCure, Inc. | -3.68 Million USD | 17388.056% |
| Onconetix, Inc. | -1.12 Million USD | 56603.884% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 2298.605% |
| Opthea Limited | 21.72 Thousand USD | -2932183.61% |
| Psyence Biomedical Ltd. | -240.00 USD | 265371766.667% |
| Vaxcyte, Inc. | -75 Million USD | 949.189% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 1111100.244% |
| Precigen, Inc. | 106 Thousand USD | -600741.509% |
| Pharming Group N.V. | 220.1 Million USD | -189.36% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -123568.35% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -63021.11% |
| PureTech Health plc | -1.6 Million USD | 39831.254% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -480.195% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 451.083% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 1505.167% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 2996.675% |
| Acelyrin, Inc. | -115 Thousand USD | 553919.13% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 6336703.323% |
| Summit Therapeutics Inc. | -2.05 Million USD | 31167.902% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 111639.755% |
| Senti Biosciences, Inc. | -2.68 Million USD | 23838.054% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -15621.846% |
| Elevation Oncology, Inc. | -39 Thousand USD | 1633156.41% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 13374.114% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 16256.374% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -2086.453% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -128305.645% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 1158085.455% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -511.814% |
| Seer, Inc. | 7.02 Million USD | -8963.498% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -14447.556% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -2856.101% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 537602.426% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 444543.514% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -104479.967% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -428.655% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -103.044% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 12737940.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -24643.279% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 1255306.937% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -2067.258% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 274622.414% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 129549.593% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 9072.837% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 134311.086% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 6124061.538% |
| Soligenix, Inc. | 97.31 Thousand USD | -654391.27% |
| Century Therapeutics, Inc. | -10.8 Million USD | 5992.238% |
| Kura Oncology, Inc. | -849 Thousand USD | 75116.726% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 1049.112% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 433359.864% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -543.072% |
| Autolus Therapeutics plc | -4.86 Million USD | 13185.926% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -1438.907% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 379202.381% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -572.373% |
| GRI Bio, Inc. | 10.84 Million USD | -5774.845% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -24974.626% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 7431.553% |
| IGM Biosciences, Inc. | -211.66 Million USD | 400.903% |
| INmune Bio, Inc. | 155 Thousand USD | -410798.065% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -928.257% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 42382.135% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 98316.99% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 2175723.42% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -158330.846% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 32008.417% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 203579.872% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -574.238% |
| Verastem, Inc. | -62 Thousand USD | 1027345.161% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -26055.729% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 244119.923% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -20940.37% |
| Histogen Inc. | 3.76 Million USD | -16798.169% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -110437.177% |
| Surrozen, Inc. | -27.23 Million USD | 2438.935% |
| Organovo Holdings, Inc. | -5.38 Million USD | 11918.371% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 52959.372% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 2583.3% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -3076.202% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 32166362.626% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -10398.641% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 948830.095% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -311.453% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -436725.789% |
| Apollomics, Inc. | 127 Thousand USD | -501389.764% |
| Amarin Corporation plc | 165.54 Million USD | -284.734% |
| Mesoblast Limited | -9.81 Million USD | 6588.966% |
| Turnstone Biologics Corp. | 16.5 Million USD | -3758.548% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 676.43% |
| Synaptogenix, Inc. | -6347.00 USD | 10034636.001% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 1248907.843% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -294.69% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 63.765% |
| Better Therapeutics, Inc. | -2.72 Million USD | 23437.926% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 667.837% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -88.384% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 5582954.137% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 10273.994% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 57581.227% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -8603.087% |
| Insmed Incorporated | 239.63 Million USD | -165.776% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -17700.224% |
| OmniAb, Inc. | 14.66 Million USD | -4242.347% |
| Alector, Inc. | -95.05 Million USD | 770.039% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -406.995% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 1565.366% |
| Zai Lab Limited | 170.9 Million USD | -272.663% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -677.864% |
| Aura Biosciences, Inc. | -1.29 Million USD | 49280.849% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -489816.923% |
| Immunic, Inc. | -111 Thousand USD | 573876.577% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -3917.232% |
| Veracyte, Inc. | 248.14 Million USD | -156.658% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 109.113% |
| FibroGen, Inc. | 128.9 Million USD | -394.082% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 112924213.475% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 5558.972% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 81.26% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -163625.45% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -79.232% |
| TG Therapeutics, Inc. | 219.1 Million USD | -190.675% |
| Galecto, Inc. | -830 Thousand USD | 76833.976% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 46084.982% |
| Fortrea Holdings Inc. | 424 Million USD | -50.21% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 839.137% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 112426.631% |
| XBiotech Inc. | -1.74 Million USD | 36619.037% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 57581.227% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 1470.515% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 943.186% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -767.665% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -3690.347% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -63.709% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 1382.841% |
| Vaxxinity, Inc. | -2.23 Million USD | 28609.042% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -94.917% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 5724.346% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -2504.769% |
| NexImmune, Inc. | -1.02 Million USD | 62237.502% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -11794196.296% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 9063.17% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 94.364% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 953145.925% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 18035.567% |
| Ainos, Inc. | -253.73 Thousand USD | 251108.738% |
| Pluri Inc. | 322 Thousand USD | -197692.547% |
| Prothena Corporation plc | -129.2 Million USD | 592.947% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -1163.075% |
| Celularity Inc. | 6.75 Million USD | -9328.453% |
| Rallybio Corporation | -150 Thousand USD | 424694.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 2053.237% |
| MeiraGTx Holdings plc | 287 Thousand USD | -221813.589% |
| Omeros Corporation | -69.77 Million USD | 1012.727% |
| Humacyte, Inc. | -76.55 Million USD | 931.995% |
| Immunocore Holdings plc | 248.39 Million USD | -156.407% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 4298.642% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -920.955% |
| Blueprint Medicines Corporation | 236.58 Million USD | -169.203% |
| CalciMedica, Inc. | -58 Thousand USD | 1098189.655% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 44762.833% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -2092.022% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 22494.233% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 2163.476% |
| Pulmatrix, Inc. | -8.22 Million USD | 7848.078% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 54535.214% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 159722.055% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 259.705% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -22846.226% |
| Cytokinetics, Incorporated | -322.59 Million USD | 297.429% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -73776.384% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 186871.848% |
| Vor Biopharma Inc. | -3.49 Million USD | 18338.603% |
| Roivant Sciences Ltd. | 109.23 Million USD | -483.048% |
| Evogene Ltd. | 1.39 Million USD | -45424.803% |
| ProKidney Corp. | -3.16 Million USD | 20197.57% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 1550.383% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -9188.202% |
| CorMedix Inc. | -205.56 Thousand USD | 309929.638% |
| BioLineRx Ltd. | 1.1 Million USD | -57381.227% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 909.564% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 1930075.758% |
| Atai Life Sciences N.V. | -5000.00 USD | 12737940.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 522746.665% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 663529.167% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 45952.556% |
| Sagimet Biosciences Inc. | 2 Million USD | -31744.6% |
| MediciNova, Inc. | 979.7 Thousand USD | -64908.548% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 855.336% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 673667.765% |
| GeoVax Labs, Inc. | -20.72 Million USD | 3173.689% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -160.45% |
| Biomea Fusion, Inc. | -4.2 Million USD | 15260.486% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 26.99% |
| Mereo BioPharma Group plc | 7.42 Million USD | -8476.515% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 205549.032% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 5307533.333% |
| Absci Corporation | -41.84 Million USD | 1621.881% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 12737940.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 933.923% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 25979.399% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -197.982% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 67782.465% |
| Allakos Inc. | -6.14 Million USD | 10471.145% |
| Imunon, Inc. | -720 Thousand USD | 88556.608% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 1023.085% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -33.831% |
| BioAtla, Inc. | -103.73 Million USD | 713.984% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 5582954.137% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 357904.494% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 362.291% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 204888.424% |
| XOMA Corporation | 3.86 Million USD | -16395.519% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 1008.742% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -4205.07% |
| aTyr Pharma, Inc. | -2.38 Million USD | 26770.519% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -5011.493% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 2196279.31% |
| Viridian Therapeutics, Inc. | -1 Million USD | 63283.73% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -4899169130.769% |
| Akari Therapeutics, Plc | -4000.00 USD | 15922400.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -327001.095% |
| UroGen Pharma Ltd. | 73.35 Million USD | -768.268% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 2485.899% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -5485619.208% |
| Orgenesis Inc. | -5.72 Million USD | 11224.751% |
| Entera Bio Ltd. | -56 Thousand USD | 1137407.143% |
| GH Research PLC | -315 Thousand USD | 202287.937% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 337079.894% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 121412.762% |
| Xencor, Inc. | -85.26 Million USD | 847.0% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 288316.421% |
| Replimune Group, Inc. | -2.65 Million USD | 24088.399% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 63710.577% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -258.118% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -327001.095% |
| Portage Biotech Inc. | -54 Thousand USD | 1179529.63% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 673667.765% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 169036.87% |
| OncoCyte Corporation | 413 Thousand USD | -154111.138% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 14168998.776% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 286888388.288% |
| Purple Biotech Ltd. | -196 Thousand USD | 325044.898% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -7001.829% |
| scPharmaceuticals Inc. | 9.78 Million USD | -6410.857% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 6197.603% |
| HilleVax, Inc. | -2.15 Million USD | 29640.445% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 656689.691% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 4244914.716% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 95443.114% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 2769195.652% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 8485024.382% |
| Savara Inc. | -44.26 Million USD | 1538.914% |
| Curis, Inc. | 9.81 Million USD | -6391.611% |
| Daré Bioscience, Inc. | 2.76 Million USD | -22896.459% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 510479.203% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 36935.859% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 279438.596% |
| BeiGene, Ltd. | 2.07 Billion USD | 69.363% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 22879.499% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 259.357% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -1023.504% |
| Erasca, Inc. | -3.73 Million USD | 17165.702% |
| bluebird bio, Inc. | -4.03 Million USD | 15903.772% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 2257141.605% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 66.556% |
| DBV Technologies S.A. | 15.72 Million USD | -3949.415% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 2257141.605% |
| Moderna, Inc. | 2.15 Billion USD | 70.446% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 69705.683% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -7855.184% |
| Molecular Templates, Inc. | 50.39 Million USD | -1163.8% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 118923.134% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -376.046% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 10336.13% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 1718.819% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 673.116% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 17850.613% |
| MacroGenics, Inc. | 50.52 Million USD | -1160.498% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 10544.277% |
| Prime Medicine, Inc. | -147.9 Million USD | 530.609% |
| Aditxt, Inc. | -111.66 Thousand USD | 570485.098% |
| Adagene Inc. | 18.11 Million USD | -3416.508% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -130410.656% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -354.267% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -303.515% |
| SciSparc Ltd. | 2.19 Million USD | -28902.368% |
| Vericel Corporation | 135.57 Million USD | -369.768% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 2542684.534% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 2055783.946% |
| Generation Bio Co. | -73.91 Million USD | 961.701% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 145841.876% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -1066.063% |
| Invivyd, Inc. | -2.02 Million USD | 31504.931% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 311.704% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 615823.429% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -560.896% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -547.986% |
| ADMA Biologics, Inc. | 88.21 Million USD | -621.952% |
| Clene Inc. | 533 Thousand USD | -119391.932% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -2541.699% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 66650.888% |
| GeoVax Labs, Inc. | -20.72 Million USD | 3173.689% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -31936.821% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 327860.967% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -1178.771% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 9080.429% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 76283.254% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -663.522% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -871018.284% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -1098.021% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 467.746% |
| Trevena, Inc. | 1.45 Million USD | -43672.646% |
| Surrozen, Inc. | -27.23 Million USD | 2438.935% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 180522.663% |
| Cingulate Inc. | -582.91 Thousand USD | 109359.278% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 2054590.323% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 3333.118% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 8413468.56% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 72391.941% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 6.437% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 64562.753% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 1130503.607% |
| Kronos Bio, Inc. | 1.37 Million USD | -46320.7% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 1286.77% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 218213.699% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 130526.734% |
| ImmunityBio, Inc. | -17.89 Million USD | 3660.045% |
| Korro Bio, Inc. | -3.63 Million USD | 17645.234% |
| Kineta, Inc. | 5.43 Million USD | -11622.658% |
| BioVie Inc. | -229.37 Thousand USD | 277761.666% |
| Codexis, Inc. | 57.33 Million USD | -1010.845% |
| Celularity Inc. | 6.75 Million USD | -9328.453% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -15770.72% |
| Celcuity Inc. | -142.77 Thousand USD | 446190.27% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -1258828.642% |
| Cibus, Inc. | 1.42 Million USD | -44688.467% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 170391.979% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 2878.882% |
| IN8bio, Inc. | -2.5 Million USD | 25565.494% |
| Kodiak Sciences Inc. | -25.94 Million USD | 2554.588% |
| Annexon, Inc. | -3.26 Million USD | 19594.705% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 31259.1% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 1625.965% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -99414.375% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 18.191% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -268.241% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 33620.632% |
| Arcellx, Inc. | 108.27 Million USD | -488.195% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 2067.599% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -704.116% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 3111.025% |
| Moolec Science SA | -143.3 Thousand USD | 444531.108% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 1605.014% |
| Geron Corporation | -123.5 Million USD | 615.689% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -19276.088% |
| Royalty Pharma plc | 1.79 Billion USD | 64.497% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 1008.677% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 17632768.882% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -275144.932% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 671.644% |
| Humacyte, Inc. | -76.55 Million USD | 931.995% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 67199.604% |
| 89bio, Inc. | -273 Thousand USD | 233393.773% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 50767.621% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 75205.189% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 517898.374% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -56816.175% |
| Notable Labs, Ltd. | 113 Thousand USD | -563521.239% |
| Liquidia Corporation | 14.6 Million USD | -4262.274% |
| Mustang Bio, Inc. | -2.22 Million USD | 28724.36% |
| Immunovant, Inc. | -231 Thousand USD | 275810.823% |
| Quantum-Si incorporated | 488 Thousand USD | -130410.656% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 1246.335% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 2123073.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -34104.726% |
| Acasti Pharma Inc. | -11 Thousand USD | 5790027.273% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 311360.55% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 98316.99% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 480.207% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -56034.605% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 167263.255% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 32627.681% |
| PepGen Inc. | -1.18 Million USD | 53891.554% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 501589.764% |
| United Therapeutics Corporation | 2.07 Billion USD | 69.232% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 2881.552% |
| Solid Biosciences Inc. | -76.56 Million USD | 931.854% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 771314.415% |
| Immuneering Corporation | -764.13 Thousand USD | 83447.772% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -961043.306% |
| Belite Bio, Inc | -399 Thousand USD | 159722.055% |
| XOMA Corporation | 3.86 Million USD | -16395.519% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 3278.738% |
| Bionomics Limited | -434.44 Thousand USD | 146697.644% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 59400.931% |
| uniQure N.V. | 2.21 Million USD | -28653.589% |
| Cassava Sciences, Inc. | -89.42 Million USD | 812.224% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 791.755% |
| Forte Biosciences, Inc. | -9000.00 USD | 7076677.778% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 76374.491% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 145841.876% |
| Altimmune, Inc. | -65.37 Million USD | 1074.243% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -75.922% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 59400.931% |
| Compugen Ltd. | 31.45 Million USD | -1924.772% |
| Peak Bio, Inc. | 367.76 Thousand USD | -173077.185% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -2497.863% |
| Benitec Biopharma Inc. | 108 Thousand USD | -589614.815% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 816628.205% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 53041.978% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 35055.653% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 535303.361% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 53041.978% |
| Instil Bio, Inc. | -4.75 Million USD | 13491.337% |
| argenx SE | 1.1 Billion USD | 42.544% |
| Immunome, Inc. | -8.9 Million USD | 7250.466% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 33797.989% |
| Verona Pharma plc | -679.62 Thousand USD | 93812.406% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 364038.286% |
| Shattuck Labs, Inc. | -2.38 Million USD | 26804.067% |
| CervoMed Inc. | -1.29 Million USD | 49333.048% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 26559.992% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 13432.468% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -25674.666% |
| Moolec Science SA | -143.3 Thousand USD | 444531.108% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 156189.503% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 23939.99% |
| AnaptysBio, Inc. | 14.78 Million USD | -4208.856% |
| Design Therapeutics, Inc. | -537 Thousand USD | 118701.862% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 149255.035% |
| NeurAxis, Inc. | 2.15 Million USD | -29430.803% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -29578.099% |
| Lumos Pharma, Inc. | 2 Million USD | -31633.533% |
| Achilles Therapeutics plc | -4.73 Million USD | 13561.341% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 364038.286% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 602789.378% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -1911.741% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -73776.384% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 61814.341% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 1498.288% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -1481044.186% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 77580.779% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 4840440.477% |
| Palisade Bio, Inc. | 246 Thousand USD | -258799.187% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 1930075.758% |
| Beam Therapeutics Inc. | -59.67 Million USD | 1167.321% |
| Neurogene Inc. | -3.26 Million USD | 19624.586% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -357.094% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 17350.596% |
| Sesen Bio, Inc. | 40 Million USD | -1492.23% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 214541.751% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 15915.4% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 6757.872% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -4423.381% |
| Athira Pharma, Inc. | -969 Thousand USD | 65826.729% |
| Vaccinex, Inc. | -16 Million USD | 4079.58% |
| HCW Biologics Inc. | -574.82 Thousand USD | 110897.74% |
| XOMA Corporation | 3.86 Million USD | -16395.519% |
| Nektar Therapeutics | 53.47 Million USD | -1090.942% |
| Arvinas, Inc. | 71.8 Million USD | -787.036% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 863.101% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 1114.563% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 197892.547% |
| Rezolute, Inc. | -36 Thousand USD | 1769244.444% |
| Clene Inc. | 533 Thousand USD | -119391.932% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 49602280.685% |
| BeyondSpring Inc. | 1.75 Million USD | -36273.044% |
| Synlogic, Inc. | -1.92 Million USD | 33202.495% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 1721429.73% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 10158.307% |
| Peak Bio, Inc. | 367.76 Thousand USD | -173077.185% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 3458.604% |
| Krystal Biotech, Inc. | 47.6 Million USD | -1237.868% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -351.405% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -12574.468% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 24697.842% |
| MannKind Corporation | 136.19 Million USD | -367.646% |
| Ikena Oncology, Inc. | -50.49 Million USD | 1361.372% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -485.303% |
| Gossamer Bio, Inc. | -4.38 Million USD | 14624.333% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 252834.921% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 12737940.0% |
| Legend Biotech Corporation | 140.92 Million USD | -351.924% |
| Mural Oncology plc | -2.56 Million USD | 24910.752% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 115688.385% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 636992.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -2968.767% |
| REGENXBIO Inc. | 53.02 Million USD | -1101.026% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 11989.072% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 331167.966% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 36872.055% |
| Vaxart, Inc. | -60.76 Million USD | 1148.158% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 242466.999% |
| Cellectis S.A. | 18 Thousand USD | -3538188.889% |
| Longeveron Inc. | 221 Thousand USD | -288086.425% |
| Repare Therapeutics Inc. | -80.07 Million USD | 895.419% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 41.73% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 49318.856% |
| Revolution Medicines, Inc. | -399.66 Million USD | 259.357% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 1819791.429% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -1299679.592% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 92.6% |
| Denali Therapeutics Inc. | -93.34 Million USD | 782.299% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 2542684.534% |
| Veru Inc. | 7.56 Million USD | -8317.897% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 421882.781% |
| Cingulate Inc. | -582.91 Thousand USD | 109359.278% |
| Passage Bio, Inc. | -3.72 Million USD | 17216.152% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 5288143.839% |
| Exicure, Inc. | -1.42 Million USD | 44856.992% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 166390.339% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -23462.412% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 124329.19% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -834.874% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 425810.027% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 1175.722% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -162787.98% |
| OmniAb, Inc. | 14.66 Million USD | -4242.347% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -3085.575% |
| Lipocine Inc. | -2.85 Million USD | 22440.676% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 34657.352% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 11263.751% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 42382.135% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -745.626% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 979933.846% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -655.542% |
| Ocugen, Inc. | -33.53 Million USD | 1999.073% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 20242.062% |
| Q32 Bio Inc. | 578 Thousand USD | -110088.927% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 240436.604% |
| Alumis Inc. Common Stock | -1.28 Million USD | 49702.181% |
| Equillium, Inc. | 35.95 Million USD | -1671.211% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 37410.603% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -127105.655% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 15406292.55% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 246004.247% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -150568.067% |
| Dominari Holdings Inc. | 2.03 Million USD | -31135.508% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 347234.97% |
| vTv Therapeutics Inc. | -13.59 Million USD | 4784.752% |
| Bio-Techne Corporation | 773.07 Million USD | 17.616% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -3577.418% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -38.219% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 54581.779% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 2755.93% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -5344.918% |
| Nkarta, Inc. | -5.86 Million USD | 10951.798% |
| BioCardia, Inc. | -7.24 Million USD | 8885.929% |
| Iterum Therapeutics plc | -1.75 Million USD | 36493.829% |